According to GlobalData’s medical device pipeline database, 37 Endoscopy Visualization Systems devices are in various stages of development globally. GlobalData’s report Endoscopy Visualization Systems provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.

Smarter leaders trust GlobalData

Of these devices, 17 are in active development, while the remaining 20 are in an inactive stage of development. There are 11 products in the early stages of development, and the remaining six are in the late stages of development.

Endoscopy Visualization Systems aid in visualization and interpretation of the endoscopic images. In this model, a complete unit of Endoscopy Visualization System is tracked. Individual parts from different companies assembled together to form one Endoscopy Visualization System are not tracked here. New units refer to the first time purchases of the complete system. The Endoscopy Visualization Systems are classified into low end, mid range and high end based on the average selling price (ASP) of these systems. One unit refers to one Endoscopy Visualization Systems which comprises Camera Head(s), Light Source(s), Monitor(s), Video Processor and other components. Other components include Insufflator and Printer which are not definite components of Endoscopy Visualization Systems. Various endoscopes (Bronchoscopes, Laparoscopes, Colonoscopes, etc.) which come with an Endoscopy Visualization System are not included here. In this segment, a complete unit of Endoscopy Visualization System is tracked. Individual parts from different companies assembled together to form one Endoscopy Visualization System are not tracked here. New units refer to the first time purchases of the complete system.

Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.

Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Endoscopy Visualization Systems pipeline devices are all expected to be approved within the next ten years.

Currently, private organizations, public entities and institutions are working on the development of Endoscopy Visualization Systems devices. Overall, most of these Endoscopy Visualization Systems pipeline devices are being developed by private entities.

Key players involved in the active development of Endoscopy Visualization Systems include Olympus Endo Technology America, Olympus Medical Systems, Otsuka Medical Devices, Shenzhen Edge Medical, Showa University, Spectral Molecular Imaging, Texas A&M Engineering Experiment Station, University of Arkansas, University of California Irvine and University of California San Diego.

For a complete picture of the developmental pipeline for Endoscopy Visualization Systems devices, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.